Catalent, Inc. to Present at the Barclays Global Healthcare Conference
SOMERSET, N.J.--(BUSINESS WIRE)--Mar 9, 2020--
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products, today announced that Wetteny Joseph, Senior Vice President & Chief Financial Officer, will present via virtual meeting at the Barclays Global Healthcare Conference at 10:15 a.m. ET on Thursday, March 12, 2020.
A live webcast of the presentation will be accessible through the Company’s website at http://investor.catalent.com and will be available for replay following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT) is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs more than 13,000 people, including approximately 2,400 scientists, at more than 35 facilities across four continents and in fiscal 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, please visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source version on businesswire.com:https://www.businesswire.com/news/home/20200309005852/en/
Paul Surdez, Catalent, Inc.
KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH GENETICS PHARMACEUTICAL MEDICAL SUPPLIES
SOURCE: Catalent, Inc.
Copyright Business Wire 2020.
PUB: 03/09/2020 06:45 PM/DISC: 03/09/2020 06:45 PM